Dufour JF - Search Results

1

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, Allison ME, Alexander GJ, Piguet AC, Anty R, Donaldson P, Aithal GP, Francque S, Van Gaal L, Clement K, Ratziu V, Dufour JF, Day CP, Daly AK, Anstee QM. Liu YL, et al. Among authors: dufour jf. Nat Commun. 2014 Jun 30;5:4309. doi: 10.1038/ncomms5309. Nat Commun. 2014. PMID: 24978903 Free PMC article.

2

Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations.

Oneta CM, Dufour JF. Oneta CM, et al. Among authors: dufour jf. Swiss Med Wkly. 2002 Sep 7;132(35-36):493-505. doi: 10.4414/smw.2002.10001. Swiss Med Wkly. 2002. PMID: 12506331 Free article. Review.

3

Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.

Wang L, Piguet AC, Schmidt K, Tordjmann T, Dufour JF. Wang L, et al. Among authors: dufour jf. Hepatology. 2005 Jun;41(6):1241-51. doi: 10.1002/hep.20697. Hepatology. 2005. PMID: 15861431

4

Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma.

Martin J, Magnino F, Schmidt K, Piguet AC, Lee JS, Semela D, St-Pierre MV, Ziemiecki A, Cassio D, Brenner C, Thorgeirsson SS, Dufour JF. Martin J, et al. Among authors: dufour jf. Gastroenterology. 2006 Jun;130(7):2179-88. doi: 10.1053/j.gastro.2006.03.024. Gastroenterology. 2006. PMID: 16762638 Free PMC article.

5

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.

Roth P, Hammer C, Piguet AC, Ledermann M, Dufour JF, Waelti E. Roth P, et al. Among authors: dufour jf. J Drug Target. 2007 Nov;15(9):623-31. doi: 10.1080/10611860701502723. J Drug Target. 2007. PMID: 17968716

6

Targeting vessels to treat hepatocellular carcinoma.

Romanque P, Piguet AC, Dufour JF. Romanque P, et al. Among authors: dufour jf. Clin Sci (Lond). 2008 Apr;114(7):467-77. doi: 10.1042/CS20070310. Clin Sci (Lond). 2008. PMID: 18302534 Review.

7

Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma.

Piguet AC, Semela D, Keogh A, Wilkens L, Stroka D, Stoupis C, St-Pierre MV, Dufour JF. Piguet AC, et al. Among authors: dufour jf. J Hepatol. 2008 Jul;49(1):78-87. doi: 10.1016/j.jhep.2008.03.024. Epub 2008 Apr 28. J Hepatol. 2008. PMID: 18486258

8

Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.

Piguet AC, Stroka D, Zimmermann A, Dufour JF. Piguet AC, et al. Among authors: dufour jf. Clin Sci (Lond). 2009 Dec 14;118(6):401-10. doi: 10.1042/CS20090313. Clin Sci (Lond). 2009. PMID: 19832698

9

Significance of serum adiponectin levels in patients with chronic liver disease.

Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF. Balmer ML, et al. Among authors: dufour jf. Clin Sci (Lond). 2010 Aug 5;119(10):431-6. doi: 10.1042/CS20100008. Clin Sci (Lond). 2010. PMID: 20524936 Free PMC article.

10

PI(3)K/PTEN/AKT pathway.

Piguet AC, Dufour JF. Piguet AC, et al. Among authors: dufour jf. J Hepatol. 2011 Jun;54(6):1317-9. doi: 10.1016/j.jhep.2010.12.013. Epub 2010 Dec 17. J Hepatol. 2011. PMID: 21168457 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page